Discovery of the Cryptic Sites of SARS-CoV-2 Papain-like Protease and Analysis of Its Druggability

In late 2019, a new coronavirus (CoV) caused the outbreak of a deadly respiratory disease, resulting in the COVID-19 pandemic. In view of the ongoing pandemic, there is an immediate need to find drugs to treat patients. SARS-CoV-2 papain-like cysteine protease (PLpro) not only plays an important rol...

Full description

Bibliographic Details
Main Authors: Yue Qiu, Qing Liu, Gao Tu, Xiao-Jun Yao
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/19/11265
_version_ 1797479097395314688
author Yue Qiu
Qing Liu
Gao Tu
Xiao-Jun Yao
author_facet Yue Qiu
Qing Liu
Gao Tu
Xiao-Jun Yao
author_sort Yue Qiu
collection DOAJ
description In late 2019, a new coronavirus (CoV) caused the outbreak of a deadly respiratory disease, resulting in the COVID-19 pandemic. In view of the ongoing pandemic, there is an immediate need to find drugs to treat patients. SARS-CoV-2 papain-like cysteine protease (PLpro) not only plays an important role in the pathogenesis of the virus but is also a target protein for the development of inhibitor drugs. Therefore, to develop targeted inhibitors, it is necessary to analyse and verify PLpro sites and explore whether there are other cryptic binding pockets with better activity. In this study, first, we detected the site of the whole PLpro protein by sitemap of Schrödinger (version 2018), the cavity of LigBuilder V3, and DeepSite, and roughly judged the possible activated binding site area. Then, we used the mixed solvent dynamics simulation (MixMD) of probe molecules to induce conformational changes in the protein to find the possible cryptic active sites. Finally, the TRAPP method was used to predict the druggability of cryptic pockets and analyse the changes in the physicochemical properties of residues around these sites. This work will help promote the research of SARS-CoV-2 PLpro inhibitors.
first_indexed 2024-03-09T21:40:52Z
format Article
id doaj.art-25bce4ea34094471b126c03ca9cae0c2
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T21:40:52Z
publishDate 2022-09-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-25bce4ea34094471b126c03ca9cae0c22023-11-23T20:30:12ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-09-0123191126510.3390/ijms231911265Discovery of the Cryptic Sites of SARS-CoV-2 Papain-like Protease and Analysis of Its DruggabilityYue Qiu0Qing Liu1Gao Tu2Xiao-Jun Yao3Dr. Neher’s Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau, ChinaDr. Neher’s Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau, ChinaDr. Neher’s Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau, ChinaDr. Neher’s Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau Institute for Applied Research in Medicine and Health, Macau University of Science and Technology, Taipa, Macau, ChinaIn late 2019, a new coronavirus (CoV) caused the outbreak of a deadly respiratory disease, resulting in the COVID-19 pandemic. In view of the ongoing pandemic, there is an immediate need to find drugs to treat patients. SARS-CoV-2 papain-like cysteine protease (PLpro) not only plays an important role in the pathogenesis of the virus but is also a target protein for the development of inhibitor drugs. Therefore, to develop targeted inhibitors, it is necessary to analyse and verify PLpro sites and explore whether there are other cryptic binding pockets with better activity. In this study, first, we detected the site of the whole PLpro protein by sitemap of Schrödinger (version 2018), the cavity of LigBuilder V3, and DeepSite, and roughly judged the possible activated binding site area. Then, we used the mixed solvent dynamics simulation (MixMD) of probe molecules to induce conformational changes in the protein to find the possible cryptic active sites. Finally, the TRAPP method was used to predict the druggability of cryptic pockets and analyse the changes in the physicochemical properties of residues around these sites. This work will help promote the research of SARS-CoV-2 PLpro inhibitors.https://www.mdpi.com/1422-0067/23/19/11265COVID-19SARS-CoV-2 PLproMixMDProbeviewTRAPPdruggability
spellingShingle Yue Qiu
Qing Liu
Gao Tu
Xiao-Jun Yao
Discovery of the Cryptic Sites of SARS-CoV-2 Papain-like Protease and Analysis of Its Druggability
International Journal of Molecular Sciences
COVID-19
SARS-CoV-2 PLpro
MixMD
Probeview
TRAPP
druggability
title Discovery of the Cryptic Sites of SARS-CoV-2 Papain-like Protease and Analysis of Its Druggability
title_full Discovery of the Cryptic Sites of SARS-CoV-2 Papain-like Protease and Analysis of Its Druggability
title_fullStr Discovery of the Cryptic Sites of SARS-CoV-2 Papain-like Protease and Analysis of Its Druggability
title_full_unstemmed Discovery of the Cryptic Sites of SARS-CoV-2 Papain-like Protease and Analysis of Its Druggability
title_short Discovery of the Cryptic Sites of SARS-CoV-2 Papain-like Protease and Analysis of Its Druggability
title_sort discovery of the cryptic sites of sars cov 2 papain like protease and analysis of its druggability
topic COVID-19
SARS-CoV-2 PLpro
MixMD
Probeview
TRAPP
druggability
url https://www.mdpi.com/1422-0067/23/19/11265
work_keys_str_mv AT yueqiu discoveryofthecrypticsitesofsarscov2papainlikeproteaseandanalysisofitsdruggability
AT qingliu discoveryofthecrypticsitesofsarscov2papainlikeproteaseandanalysisofitsdruggability
AT gaotu discoveryofthecrypticsitesofsarscov2papainlikeproteaseandanalysisofitsdruggability
AT xiaojunyao discoveryofthecrypticsitesofsarscov2papainlikeproteaseandanalysisofitsdruggability